Ventas (NYSE:VTR – Get Free Report) announced its earnings results on Thursday. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74), FiscalAI reports. The company had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The business’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.81 EPS. Ventas updated its FY 2026 guidance to 3.780-3.880 EPS.
Ventas Price Performance
Shares of NYSE:VTR opened at $79.82 on Friday. The firm has a 50 day moving average of $78.09 and a 200-day moving average of $73.08. Ventas has a 12 month low of $58.72 and a 12 month high of $81.89. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 1.01. The stock has a market capitalization of $37.49 billion, a PE ratio of 153.49, a PEG ratio of 1.94 and a beta of 0.77.
Ventas Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Tuesday, March 31st. This is a boost from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio is presently 369.23%.
Insider Activity at Ventas
Institutional Trading of Ventas
Hedge funds and other institutional investors have recently made changes to their positions in the company. NewEdge Advisors LLC boosted its position in shares of Ventas by 250.9% during the 3rd quarter. NewEdge Advisors LLC now owns 5,926 shares of the real estate investment trust’s stock valued at $415,000 after purchasing an additional 4,237 shares in the last quarter. Lido Advisors LLC increased its holdings in Ventas by 43.3% in the third quarter. Lido Advisors LLC now owns 6,047 shares of the real estate investment trust’s stock worth $426,000 after purchasing an additional 1,828 shares in the last quarter. Flow Traders U.S. LLC bought a new position in shares of Ventas during the 3rd quarter worth approximately $316,000. Brooklyn Investment Group boosted its holdings in shares of Ventas by 24.4% during the 3rd quarter. Brooklyn Investment Group now owns 2,921 shares of the real estate investment trust’s stock worth $204,000 after buying an additional 572 shares in the last quarter. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA grew its position in shares of Ventas by 15.3% during the 3rd quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA now owns 2,330 shares of the real estate investment trust’s stock worth $163,000 after buying an additional 310 shares during the period. 94.18% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on VTR. The Goldman Sachs Group started coverage on Ventas in a report on Friday, January 9th. They set a “buy” rating and a $94.00 price target for the company. Cantor Fitzgerald reissued an “overweight” rating and set a $93.00 target price on shares of Ventas in a report on Monday, January 5th. Citigroup upped their price target on shares of Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a research note on Tuesday, November 11th. Wells Fargo & Company raised their price target on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Finally, KeyCorp boosted their price objective on shares of Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Ventas presently has a consensus rating of “Moderate Buy” and a consensus price target of $81.63.
View Our Latest Report on Ventas
More Ventas News
Here are the key news stories impacting Ventas this week:
- Positive Sentiment: Company issued strong FY‑2026 EPS guidance (3.780–3.880) and framed growth in senior housing as a key driver — this outlook is a major positive catalyst for the stock. Ventas Reports Fourth Quarter and Full Year 2025 Results, Provides 2026 Outlook and Increases Dividend
- Positive Sentiment: Quarterly dividend raised to $0.52 (8.3% hike; annualized yield ~2.6%); ex‑dividend March 31 — dividend increase supports income investors and signals management confidence in cash flow. Ventas Reports Fourth Quarter and Full Year 2025 Results, Provides 2026 Outlook and Increases Dividend
- Positive Sentiment: Q4 results: FFO/EPS of $0.89 matched consensus while revenue of $1.55B topped estimates and rose ~21.7% YoY — solid operating growth that supports the improved outlook. Press Release / Slide Deck
- Neutral Sentiment: FFO matched estimates (0.89), which reduces downside surprise risk but didn’t deliver an upside beat on FFO per share. Ventas (VTR) Matches Q4 FFO Estimates
- Neutral Sentiment: Morgan Stanley maintained a Hold rating with an $80 price target — a mixed signal that tempers bullishness despite the strong guidance. Balanced Fundamentals and Moderating Returns Justify Hold Rating on Ventas
- Neutral Sentiment: Analysts’ consensus is a “Moderate Buy,” indicating mixed but generally favorable broker sentiment. Ventas, Inc. (NYSE:VTR) Given Consensus Rating of “Moderate Buy” by Analysts
- Negative Sentiment: Insider selling: CEO Debra Cafaro sold 10,322 shares — an action some investors view as a cautionary flag even if it may be routine diversification. Debra Cafaro Sells 10,322 Shares of Ventas (NYSE:VTR) Stock
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Articles
- Five stocks we like better than Ventas
- Your Bank Account Is No Longer Safe
- Trade this between 9:30 and 10:45 am EST
- New gold price target
- When to buy gold (mathematically)
- Nervous about the stock market? Read this
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
